The effect of discontinuing beta-blockers after different treatment durations following acute myocardial infarction in optimally treated, stable patients without heart failure - a Danish, nationwide cohort study.
Andrim HaliliAnders HoltTalip E ErogluSaranda HaxhaBochra ZareiniChristian Torp-PedersenCasper N BangPublished in: European heart journal. Cardiovascular pharmacotherapy (2023)
Discontinuation of beta-blockers one year or later after a myocardial infarction without heart failure was not associated with increased serious adverse events.
Keyphrases
- heart failure
- acute myocardial infarction
- left ventricular
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- angiotensin converting enzyme
- cardiac resynchronization therapy
- atrial fibrillation
- peritoneal dialysis
- acute heart failure
- cross sectional
- acute coronary syndrome
- patient reported
- replacement therapy
- smoking cessation